Journal
SLEEP MEDICINE
Volume 14, Issue 7, Pages 692-694Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.sleep.2013.04.013
Keywords
Glial fibrillary acidic protein; GFAP; Narcolepsy; Cataplexy; Cerebrospinal fluid; Hypocretin-1; Astrogliosis
Categories
Funding
- Landesstiftung Baden-Wurttemberg German ministry of science and technology
- European commission
Ask authors/readers for more resources
Glial fibrillary acidic protein (GFAP) is an established indicator of astrogliosis. Therefore, variable cerebrospinal fluid (CSF) concentrations of this protein might reflect disease-specific pathologic profiles. In patients with narcolepsy, a loss of hypocretin-1 (hcrt-1) neurons in the brain and low concentrations of hcrt-1 in CSF have been reported. We performed a commercially available enzyme-linked immunosorbent assay to investigate if GFAP also is altered in the CSF of these patients. Here we detected significantly higher CSF levels of GFAP in patients with low hcrt-1 levels, of which the majority had a diagnosis of narcolepsy and cataplexy (NC); however, this finding was not observed in patients with hcrt-1 levels that were within reference range. In conclusion, GFAP may be useful as an additional disease biomarker in patients with narcolepsy, and this hypothesis should be investigated in larger studies. (c) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available